CClinicalTrials.gg
CompletedNCT04756011Updated Feb 23, 2021

Health-related Quality of Life and Psychosocial Aspects of Diabetes Technology (Insulin Pumps)

An observational study in T1DM, Health Related Quality of Life and Insulin Pump, sponsored by Ain Shams University. Completed at 1 site in Egypt. Open to participants aged 6 Years to 18 Years. Per ClinicalTrials.gov, last updated 2021-02-23.

Sponsored by Ain Shams University · Observational

Study type
Observational
Model
Cohort
Time perspective
Cross-sectional
Enrollment
60
Ages
6 Years to 18 Years
Sex
All
01

Study summary

This study will be prospective comparative trial comparing between insulin pumps vs Multiple daily injections (MDI) in treatment of type 1 diabetes mellitus (T1DM) in terms of health- related quality of life (HRQL) and efficacy of glycemic control (HbA1c level )

Hypothesis:

Type 1 diabetes is characterized by autoimmune destruction of insulin-secreting pancreatic b cells leading to disturbed glucose regulation and overt hyperglycemia which leads to variable consequences and complication. Consequently, individuals with type 1 diabetes have a lifelong dependency on insulin replacement therapy.

Aim of the Work:

To compare the psychosocial impact of insulin pumps versus multiple daily injections in treatment of type 1 diabetes mellitus (Via questionnaire) in terms of health-related quality of life and efficacy of glycemic control (HbA1c level).

02

Conditions studied

  • T1DM
  • Health Related Quality of Life
  • Insulin Pump

Keywords

  • Insulin pump
  • T1DM
  • HRQL
03

In context

Lead sponsor

Ain Shams University is the lead sponsor of 1,876 studies on the registry; 423 are open to participants now.

Of its 32 completed or terminated interventional studies of FDA-regulated products, 0 (0%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
6 Years to 18 Years
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Patients from Ain shams pediatric and adolescent diabetes unit(PADU)

Inclusion criteria

  • 1.Type 1 diabetes mellitus.
  • 2.Patients who are on insulin pumps must be for at least 3 months on them

Exclusion criteria

Exclusion Criteria:

    1. Other types of DM e.g., T2DM, MODY.
    1. Patients with other comorbidities; cardiac, renal, neurological, hepatic ....etc.
05

Study design

Observational model
Cohort
Time perspective
Cross-sectional
Enrollment
60 participants (actual)
Target follow-up
11 Months
Patient registry
Yes

Groups and cohorts

  • Group A (insulin pump)

    30 patients who are on insulin pump.

    Other: Health related quality of life

  • Group B (MDI)

    30 patients who are on multiple daily injection.

    Other: Health related quality of life

Interventions

  • OtherHealth related quality of life

    Confidence in diabetes self care questionnaire the socioeconomic level of the family scale MINI-KID the Peds-QL

06

What researchers measure

Primary outcomes

  1. Confidence in diabetes self care questionnaire (CIDS)

    the CIDS scale, assessment included HbA1c, emotional distress, fear of hypoglycemia, self-esteem, anxiety, depression, and self-care behavior. The CIDS scale is a reliable and valid measure of diabetes-specific self-efficacy for use in patients with type 1 diabetes. High psychometric similarity allows for cross-cultural comparisons.

    Time frame: 10 min

  2. socioeconomic level of the family scale

    Assessment of family socioeconomic standard

    Time frame: 5 minutes

  3. MINI-KID (Mini International Neuropsychiatric Interview )

    Mini International Neuropsychiatric Interview for Children and Adolescents

    Time frame: 25 minutes

  4. Evaluation of health-related quality of life (HRQL)

    HRQL was measured by the Peds-QL 4.0 11,22. The 23-item Peds-QL 4.0 generic core scales encompass (a) physical functioning (eight items), (b) emotional functioning (five items), (c) social functioning (five items), and (d) school functioning (five items). The physical health summary score (eight items) is the same as the physical functioning scale. To create the psychosocial health summary score (15 items), the mean is computed as the sum of the items divided by the number of items answered in the emotional, social, and school functioning scales.

    Time frame: 5 minutes

07

Study locations

1 site
  • Ain shams University
    Cairo, Abbasia 11517, Egypt
08

References and documents

Publications

  • El Samahy MH, Salah NY, Abdeen MS, Falastin BRK. Psychosocial aspects of continuous subcutaneous insulin infusion in children with type 1 diabetes in Egypt; a limited resources country perspective. Diabetol Metab Syndr. 2022 Jun 11;14(1):82. doi: 10.1186/s13098-022-00853-6. PubMed 35690827 ↗
09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Feb 23, 2021, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT04756011
Lead sponsor
Ain Shams University
Responsible party
Sponsor
First posted
Feb 16, 2021
Start date
Mar 15, 2020
Primary completion
Jan 17, 2021
Completion
Feb 1, 2021
Last update
Feb 23, 2021

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Feb 2021. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion